|1.||Zeng, Haiying: 1 article (01/2015)|
|2.||Yang, Chunxin: 1 article (01/2015)|
|3.||Wang, Qiang: 1 article (01/2015)|
|4.||Hu, Qiongyi: 1 article (01/2015)|
|5.||Qin, Wanzhang: 1 article (01/2015)|
08/07/1997 - "We conclude that TZ-93 may be useful in treating highly vascularized and metastatic tumors as well as other angiogenic diseases."
08/07/1997 - "TZ-93 treatment of tumor-bearing mice significantly decreased the density of microvessels in the tumors. "
08/07/1997 - "The highest dose of TZ-93 significantly reduced the growth of well-vascularized tumors with volumes of more than 500 mm3. "
08/07/1997 - "wilfordii, the nortriterpenoid, demethylzeylasteral (TZ-93), inhibited the proliferation of vascular endothelial cells approximately 30 times more effectively than it did for the proliferation of human tumor cells. "
08/07/1997 - "Similarly, 0.3 mg/kg/day TZ-93 partially inhibited, and 3 or 30 mg/kg/day almost completely blocked, the growth of mouse B16-F10 melanoma cells in a tumor implantation assay. "
|4.||Melanoma (Melanoma, Malignant)